Everolimus prolongs progression-free survival for patients with neuroendocrine tumors
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of ...
Cancer
Nov 29, 2011 |
not rated yet |
0
|
Implanted neurons, grown in the lab, take charge of brain circuitry
Among the many hurdles to be cleared before human embryonic stem cells can achieve their therapeutic potential is determining whether or not transplanted cells can functionally integrate into target organs or tissues.
Neuroscience
Nov 21, 2011 |
4.9 / 5 (10) |
0
|
Study: Mycophenolate is superior to azathioprine as treatment for lupus nephritis
A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis.
Diseases, Conditions, Syndromes
Nov 16, 2011 |
not rated yet |
0
|
FDA approves first drug for bone marrow disorder
The first drug to treat a rare disorder that causes red blood cells to build up inside bone marrow was cleared Wednesday by the Food and Drug Administration
Medications
Nov 16, 2011 |
not rated yet |
0
NIH scientists outline steps toward Epstein-Barr virus vaccine
Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood ...
Diseases, Conditions, Syndromes
Nov 02, 2011 |
not rated yet |
0
|
Recipients of organ transplants at increased risk for broad range of cancers
Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an overall cancer risk that is double that of the general population, with an increased risk for many different types of malignancies, ...
Cancer
Nov 01, 2011 |
not rated yet |
0
First bilateral hand transplant performed at the Hospital of the University of Pennsylvania
For the first time in the Delaware Valley Region, a patient has undergone a complex and intricate bilateral hand transplant that could significantly enhance the quality-of-life for persons with multiple limb loss. The procedure ...
Other
Nov 01, 2011 |
not rated yet |
0
Never too old to donate a kidney?
People over age 70 years of age can safely donate a kidney, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results provide good news for patients ...
Other
Oct 28, 2011 |
not rated yet |
0
NYC man pleads guilty to kidney trafficking
(AP) -- A New York man pleaded guilty Thursday to what experts said was the first ever proven case of black-market organ trafficking in the United States.
Other
Oct 27, 2011 |
not rated yet |
0
High-dose melphalan and autologous stem cell transplantation increases survival
A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation ...
Cancer
Oct 26, 2011 |
1 / 5 (1) |
0
|
Biomarker detects graft-versus-host-disease in cancer patients after bone marrow transplant
A University of Michigan Health System-led team of researchers has found a biomarker they believe can help rapidly identify one of the most serious complications in patients with leukemia, lymphoma and other blood disorders ...
Medical research
Oct 21, 2011 |
not rated yet |
0
|
Study uncovers why anti-rejection drugs for transplant patients cause hypertension
Modern medicine's ability to save lives through organ transplantation has been revolutionized by the development of drugs that prevent the human body from rejecting the transplanted organ.
Medications
Oct 07, 2011 |
not rated yet |
0
|
Timing is crucial for family consent in brain dead organ donors
Hearts used in transplants can only be sourced from donors that are brain dead before circulation to their heart has ceased. Data from a study published in BioMed Central's open access journal Critical Care indicate that t ...
Other
Oct 07, 2011 |
5 / 5 (1) |
0
Circadian clock may impact organ transplant success
Health care providers assess blood and tissue type as well as organ size and health to enhance transplant success. New research indicates that checklist might also need to include the circadian clock.
Medical research
Oct 04, 2011 |
not rated yet |
0
|
Living donor liver transplantation improves survival over deceased donor transplants
New research shows liver transplantation candidates without hepatocellular carcinoma (HCC) derive a greater survival benefit from a living donor liver transplant (LDLT) than waiting for a deceased donor liver transplant (DDLT). ...
Other
Sep 27, 2011 |
not rated yet |
0
